Thrombopoietin increases susceptibility for EVI1 + KMT2A-MLLT3-driven AML expressing stem cell genes linked to poor outcome. - Châtel-Soulet HÉ; Juge S; Pereira AL; Seguin J; El Taher A; Valigi F; Jevtic Z; Sivalingam R; Bagger FO; Büschl P; Almosailleakh M; Tzankov A; et al. (Nature communications, 2025)